Exhibits superior activity against both Gram +ve and Gram -ve pathogens
Highly active against beta lactamase-pr uducing strains of H.influenzae and M. Catarrhalis
Highly effective, safe oral option for treatment of typhoid fever
Possesses enhanced antistaphylococcal activity compared to Cefixime
Achieves superior clinical cure rates 97.7% compared to Ceftriazone 95.1% in vulnerable patients with bronchopneumonia
In,Pharyngitis / Tonsillitis Chronic Bronchitis Acute Otitis Media Community Acquired Pneumonia Gynaecological Infections Urinary Tract Infections Skin Soft Tissue Infections